-Backlog at
-Conference Call on
Fiscal Year 2023 Highlights
- Backlog at
February 28, 2023 , was$8.5 million , a record high and a 60% increase compared to backlog atFebruary 28, 2022 , (“fiscal 2022"). The large increase in backlog resulted from the receipt of several large orders from the clean energy sector during the year. These orders have high average selling prices and longer than typical delivery lead times, which is often necessary for customized production scale, complex coating systems. - Net sales were
$15.1 million , a 12% decrease, compared to$17.1 million in fiscal 2022. The decline was primarily due to supply chain challenges which delayed the receipt of necessary parts to complete several customer shipments. - Gross profit decreased 11% to
$7.7 million for fiscal year 2023 compared with$8.6 million for fiscal year 2022. The gross profit margin increased to 50.8% compared to 50.3% for fiscal 2022. The increase was driven by increased efficiencies and a favorable product mix. - Operating income decreased to
$683,000 or 64% in fiscal 2023 when compared to fiscal 2022, due to the current period’s decrease in gross profit. - Net income was
$636,000 compared to$2.5 million in fiscal 2022, primarily due to decreases in operating income and income tax expense combined with PPP Loan forgiveness recorded in the prior year. - Cash, cash equivalents and marketable securities totaled
$11.4 million atFebruary 28, 2023 , the highest level ever, while the Company continues to have no debt. - For the first quarter of fiscal 2024, ending
May 31, 2023 , net sales are expected to be slightly below net sales of$3.7 million recorded in the fourth quarter of fiscal 2023 due to remaining supply chain issues. - Fiscal year 2024 net sales are projected to post positive growth, as remaining supply chain issues ease and shipments of orders from yearend backlog, including high margin multi-axis systems, resume.
Sono-Tek expects to begin shipping the large supply chain-constrained orders from backlog beginning in the second quarter of fiscal 2024, which begins onJune 1, 2023 .
Dr.
“In fact, we recently received two major orders subsequent to fiscal year end that are expected to be just the first parts of large multi-system orders going forward. One order is for over
“In addition, sales of circuit board fluxing equipment, one of our traditional markets, were strong from the recent introduction of a new platform, and spare parts sales also contributed to our successful year, in part due to more in-house vertical integration that has been put in place to avoid additional supplier problems. We intend to expand vertical integration into other areas as well, particularly in those markets that hampered us in reaching all of our quarterly goals in fiscal 2023.”
“Looking ahead, we believe that strong demand will continue for our leading edge products which, when combined with our record backlog, gives us confidence to project positive sales growth beginning with the second quarter of our new fiscal year,” concluded
Fiscal Year 2023 Review (Results compared with fiscal 2022)
($ in thousands) | ||||||||||||
Change | ||||||||||||
FY 2023 | FY 2022 | $ | % | |||||||||
$ | 15,058 | $ | 17,133 | $ | (2,075 | ) | (12 | %) | ||||
Gross Profit | $ | 7,652 | $ | 8,613 | $ | (961 | ) | (11 | %) | |||
Gross Margin | 50.8 | % | 50.30 | % | ||||||||
Operating Income | $ | 683 | $ | 1,889 | $ | (1,206 | ) | (64 | %) | |||
Operating Margin | 4.54 | % | 11.03 | % | ||||||||
Net Income | $ | 636 | $ | 2,543 | $ | (1,907 | ) | (75 | %) | |||
4.22 | % | 14.8 | % |
Fourth Quarter Fiscal 2023 Review (Results compared with the fourth quarter of fiscal 2022)
($ in thousands) | |||||||||||
Change | |||||||||||
FY 2023 | FY 2022 | $ | % | ||||||||
$ | 3,657 | $ | 4,999 | $ | (1,342 | ) | (27 | %) | |||
Gross Profit | $ | 1,825 | $ | 2,556 | $ | (731 | ) | (29 | %) | ||
Gross Margin | 49.9 | % | 51.13 | % | |||||||
Operating Income | $ | 21 | $ | 607 | $ | (586 | ) | (97 | %) | ||
.59 | % | 12.14 | % | ||||||||
Net Income | $ | 63 | $ | 556 | $ | (493 | ) | (89 | %) | ||
1.73 | % | 11.12 | % |
Fiscal Year 2023 Financial Overview
Net sales in fiscal year 2023 were
By product, revenue from multi-axis coating systems declined 32% to
By market, revenue from the Alternative Energy, Electronics, and Medical markets decreased by 17%, 23%, and 15% respectively, as large portions of all these markets use Sono-Tek’s multi-axis systems, which experienced delayed deliveries due to supply chain challenges, shifting the shipment of several planned orders from fiscal 2023 into fiscal 2024. The industrial market grew by 131% due to the shipment of 71% of a large multi-system order in fiscal 2023. The remaining 29% of the order is scheduled for shipment in the first quarter of fiscal 2024.
Geographically, in fiscal 2023, approximately 45% of sales originated in the
Backlog at
Gross profit was
Operating income was
Net income was
Balance Sheet and Cash Flow Overview
Cash, cash equivalents and marketable securities at
Capital expenditures for ongoing upgrades of the Company’s manufacturing and development lab facilities totaled
Conference Call Information
To participate, please call 1 (877) 270-2148 at least 10 minutes prior to the start of the call and ask to join the
A simultaneous webcast of the call may be accessed through the Company's website at Events & Presentations |
A replay of the call will be available at 1 (877) 344-7529, access code #3465454, through
About
The Company’s solutions are environmentally-friendly, efficient and highly reliable, and enable dramatic reductions in overspray, savings in raw material, water and energy usage and provide improved process repeatability, transfer efficiency, high uniformity and reduced emissions.
Sono-Tek’s growth strategy is focused on leveraging its innovative technologies, proprietary know-how, unique talent and experience, and global reach to further develop thin film coating technologies that enable better outcomes for its customers’ products and processes. For further information, visit www.sono-tek.com.
Safe Harbor Statement
We discuss expectations regarding our future performance, such as our business outlook, in our annual and quarterly reports, news releases, and other written and oral statements. These “forward-looking statements” are based on currently available competitive, financial and economic data and our operating plans. They are inherently uncertain, and investors must recognize that events could turn out to be significantly different from our expectations and could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, tax, competitive and technological developments affecting our operations or the demand for our products; the effects of inflation; easing of supply chain pressures that have impacted on the timely procurement of raw materials and delivery of systems and products; the continued abatement of the COVID-19 pandemic; the extent and duration of the pandemic’s adverse effect on economic and social activity, consumer confidence, discretionary spending and preferences, labor and healthcare costs, and unemployment rates, any of which may reduce demand for some of our products and impair the ability of those with whom we do business to satisfy their obligations to us; our ability to sell and provide our services and products, including as a result of continued pandemic related travel restrictions, mandatory business closures, and stay-at home or similar orders; any temporary reduction in our workforce, closures of our offices and facilities and our ability to adequately staff and maintain our operations resulting from the pandemic; the ability of our customers and suppliers to continue their operations as result of the pandemic, which could result in terminations of contracts, and losses of revenue; the recovery of the Electronics/Microelectronics and Medical markets following COVID-19 related slowdowns; maintenance of increased order backlog, including effects of any COVID-19 related cancellations; the imposition of tariffs; timely development and market acceptance of new products and continued customer validation of our coating technologies; adequacy of financing; capacity additions, the ability to enforce patents; maintenance of operating leverage; consummation of order proposals; completion of large orders on schedule and on budget; continued sales growth in the microelectronics, medical and alternative energy markets, including expected multi-system sales to existing customers; effective implementation of increased in-home vertical integration; successful transition from primarily selling ultrasonic nozzles and components to a more complex business providing complete machine solutions and higher value subsystems; and realization of quarterly and annual revenues within the forecasted range of sales guidance.
We undertake no obligation to update any forward-looking statement.
For more information, contact:
Chief Financial Officer
Ph: (845) 795-2020
info@sono-tek.com
Investor Relations:
PCG Advisory
Ph: (646) 863-6341
sprince@pcgadvisory.com
http://www.sono-tek.com
– Tables Follow –
CONSOLIDATED BALANCE SHEETS | ||||||||
2023 | 2022 | |||||||
ASSETS | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | 3,354,601 | $ | 4,840,558 | ||||
Marketable securities | 8,090,000 | 5,867,990 | ||||||
Accounts receivable (less allowance of | 1,633,866 | 1,092,505 | ||||||
Inventories | 3,242,909 | 2,373,242 | ||||||
Prepaid expenses and other current assets | 254,046 | 323,304 | ||||||
Total current assets | 16,575,422 | 14,497,599 | ||||||
Land | 250,000 | 250,000 | ||||||
Buildings, equipment, furnishings and leasehold improvements, net | 2,624,996 | 2,561,184 | ||||||
Intangible assets, net | 57,202 | 76,015 | ||||||
Deferred tax asset | 667,098 | 240,736 | ||||||
TOTAL ASSETS | $ | 20,174,718 | $ | 17,625,534 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current Liabilities: | ||||||||
Accounts payable | $ | 810,863 | $ | 684,511 | ||||
Accrued expenses | 1,427,446 | 1,804,028 | ||||||
Customer deposits | 2,838,165 | 1,167,968 | ||||||
Income taxes payable | 381,421 | 58,874 | ||||||
Total current liabilities | 5,457,895 | 3,715,381 | ||||||
Deferred tax liability | 82,865 | 168,840 | ||||||
Total Liabilities | 5,540,760 | 3,884,221 | ||||||
Commitments and Contingencies (Note 13) | ||||||||
Stockholders’ Equity | ||||||||
Common stock, | 157,421 | 157,292 | ||||||
Additional paid-in capital | 9,566,898 | 9,310,287 | ||||||
Accumulated earnings | 4,909,639 | 4,273,734 | ||||||
Total stockholders’ equity | 14,633,958 | 13,741,313 | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 20,174,718 | $ | 17,625,534 |
See accompanying notes to consolidated financial statements.
CONSOLIDATED STATEMENTS OF INCOME | ||||||||
Fiscal Year Ended | ||||||||
2023 | 2022 | |||||||
$ | 15,058,203 | $ | 17,132,710 | |||||
Cost of Goods Sold | 7,406,196 | 8,520,156 | ||||||
Gross Profit | 7,652,007 | 8,612,554 | ||||||
Operating Expenses | ||||||||
Research and product development | 2,149,525 | 1,729,509 | ||||||
Marketing and selling | 3,169,730 | 3,367,403 | ||||||
General and administrative | 1,649,761 | 1,626,306 | ||||||
Total Operating Expenses | 6,969,016 | 6,723,218 | ||||||
Operating Income | 682,991 | 1,889,336 | ||||||
Other Income (Expense): | ||||||||
Interest and Dividend Income | 140,042 | 9,496 | ||||||
Net unrealized loss on marketable securities | (33,119 | ) | — | |||||
Paycheck Protection Program Loan Forgiveness | — | 1,005,372 | ||||||
Income before Income Taxes | 789,914 | 2,904,204 | ||||||
Income Tax Expense | 154,009 | 361,631 | ||||||
Net Income | $ | 635,905 | $ | 2,542,573 | ||||
Basic Earnings Per Share | $ | 0.04 | $ | 0.16 | ||||
Diluted Earnings Per Share | $ | 0.04 | $ | 0.16 | ||||
Weighted Average Shares – Basic | 15,735,451 | 15,586,404 | ||||||
Weighted Average Shares – Diluted | 15,769,499 | 15,623,485 |
CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
Fiscal Year Ended | ||||||||
2023 | 2022 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
Net Income | $ | 635,905 | $ | 2,542,573 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 510,868 | 435,525 | ||||||
Stock based compensation expense | 256,740 | 179,283 | ||||||
Accounts receivable reserve | (43,898 | ) | — | |||||
Inventory reserve | 4,864 | 43,381 | ||||||
Paycheck Protection Program Loan Forgiveness | — | (1,005,372 | ) | |||||
Unrealized loss on marketable securities | 33,119 | _ | ||||||
Deferred tax asset, net | (512,337 | ) | (17,620 | ) | ||||
(Increase) Decrease in: | ||||||||
Accounts receivable | (497,463 | ) | 665,297 | |||||
Inventories | (874,531 | ) | 194,483 | |||||
Prepaid expenses and other assets | 69,258 | (171,988 | ) | |||||
(Decrease) Increase in: | ||||||||
Accounts payable | 126,352 | (606,241 | ) | |||||
Accrued expenses | (376,582 | ) | 53,112 | |||||
Customer deposits | 1,670,197 | 1,427 | ||||||
Income taxes payable | 322,547 | 5,307 | ||||||
Net Cash Provided by Operating Activities | 1,325,039 | 2,319,167 | ||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
Purchase of equipment, furnishings and leasehold improvements | (555,867 | ) | (326,942 | ) | ||||
Purchase of marketable securities, net | (2,255,129 | ) | (1,304,520 | ) | ||||
(2,810,996 | ) | (1,631,462 | ) | |||||
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
Proceeds from exercise of stock options | — | 68,775 | ||||||
Net Cash Provided By Financing Activities | — | 68,775 | ||||||
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | (1,485,957 | ) | 756,480 | |||||
CASH AND CASH EQUIVALENTS: | ||||||||
Beginning of year | 4,840,558 | 4,084,078 | ||||||
End of year | $ | 3,354,601 | $ | 4,840,558 | ||||
Supplemental Cash Flow Disclosure: | ||||||||
Interest Paid | $ | — | $ | — | ||||
Income Taxes Paid | $ | 363,590 | $ | 373,928 |
See accompanying notes to consolidated financial statements.
PRODUCT, MARKET, AND GEOGRAPHIC SALES | |||||||||||||||||||||||||||
Product Sales | |||||||||||||||||||||||||||
Twelve Months Ended | |||||||||||||||||||||||||||
% of | % of | Change | |||||||||||||||||||||||||
2023 | Total | 2022 | total | $ | % | ||||||||||||||||||||||
Fluxing Systems | $ | 1,179,000 | 8 | % | $ | 691,000 | 4 | % | $ | 488,000 | 71 | % | |||||||||||||||
Integrated Coating Systems | 1,114,000 | 7 | % | 1,182,000 | 7 | % | (68,000 | ) | (6 | % | ) | ||||||||||||||||
Multi-Axis Coating Systems | 6,785,000 | 45 | % | 9,912,000 | 58 | % | (3,127,000 | ) | (32 | % | ) | ||||||||||||||||
OEM Systems | 2,144,000 | 14 | % | 2,381,000 | 14 | % | (237,000 | ) | (10 | % | ) | ||||||||||||||||
Other | 3,836,000 | 26 | % | 2,967,000 | 17 | % | 869,000 | 29 | % | ||||||||||||||||||
TOTAL | $ | 15,058,000 | $ | 17,133,000 | $ | (2,075,000 | ) | (12 | % | ) |
Market Sales
Twelve Months Ended | |||||||||||||||||||||||||||
% of | % of | Change | |||||||||||||||||||||||||
2023 | Total | 2022 | total | $ | % | ||||||||||||||||||||||
Electronics/Microelectronics | $ | 5,509,000 | 37 | % | $ | 7,134,000 | 42 | % | $ | (1,625,000 | ) | (23 | % | ) | |||||||||||||
Medical | 3,702,000 | 25 | % | 4,338,000 | 25 | % | (636,000 | ) | (15 | % | ) | ||||||||||||||||
Alternative Energy | 3,060,000 | 20 | % | 3,688,000 | 22 | % | (628,000 | ) | (17 | % | ) | ||||||||||||||||
Emerging R&D and Other | 347,000 | 2 | % | 918,000 | 5 | % | (571,000 | ) | (62 | % | ) | ||||||||||||||||
Industrial | 2,440,000 | 16 | % | 1,055,000 | 6 | % | 1,385,000 | 131 | % | ||||||||||||||||||
TOTAL | $ | 15,058,000 | $ | 17,133,000 | $ | (2,075,000 | ) | (12 | % | ) |
Geographic Sales
Twelve Months Ended | |||||||||||||||||
Change | |||||||||||||||||
2023 | 2022 | $ | % | ||||||||||||||
$ | 6,804,000 | $ | 5,480,000 | $ | 1,324,000 | 24 | % | ||||||||||
3,260,000 | 5,301,000 | (2,041,000 | ) | (39 | % | ) | |||||||||||
3,448,000 | 5,255,000 | (1,807,000 | ) | (34 | % | ) | |||||||||||
1,546,000 | 1,097,000 | 449,000 | 41 | % | |||||||||||||
TOTAL | $ | 15,058,000 | $ | 17,133,000 | $ | (2,075,000 | ) | (12 | % | ) |
Source:
2023 GlobeNewswire, Inc., source